Funders · Entity Annotation Prototype (beta)

3articles mentioning funders

3funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: World Scleroderma Foundation ×

World Scleroderma Foundation

This funder is selected. Its supporting articles are shown below.

World Scleroderma Foundation3

Articles mentioning World Scleroderma Foundation

3 articles · page 1 of 1

Expert recommendations for the management of faecal incontinence in systemic sclerosis: a report from the World Scleroderma Foundation gastrointestinal ‘ad hoc committee’

jsrd · abstract · 2026-06-17 · 1 matching annotations

94.1%

World Scleroderma Foundation systemic sclerosis SSc-FI SSc Faecal incontinence (FI)

…l Steering Board (n=19) was assembled under the auspices of the World Scleroderma Foundation gastrointestinal (GI) ad hoc committee, including clinicians fr…

OC.11 Points to consider for reporting outcomes measures in systemic sclerosis interventional studies on digital ulcers: an initiative from the world scleroderma foundation digital ulcer ad hoc committee

jsrd · abstract · 2026-06-05 · 1 matching annotations

92.9%

World Scleroderma Foundation systemic sclerosis (SSc)systemic sclerosis SSc-DUs SSc SSc-DU SSc-PAH approved drugs WSF digital ulcers+1 more

…lling for more refined assessment. To address these issues, the World Scleroderma Foundation (WSF) convened an international panel of experts to develop poi…

P.036 The involvement of PDC and ER stress in systemic sclerosis-associated fibrosis

jsrd · abstract · 2026-06-05 · 1 matching annotations

90.3%

World Scleroderma Foundation Edith Busch Stiftung tunicamycin HA-15 systemic sclerosis (SSc)CL307 fibrosis SubAB iBiMED – Institute of Biomedicine subtilase cytotoxin+2 more

…trategies against tissue fibrosis.This work is supported by the World Scleroderma Foundation and Edith Busch Stiftung (Research Grant Programme 2022-2023). …